| Primary |
| Product Used For Unknown Indication |
30.6% |
| Antiplatelet Therapy |
11.3% |
| Hypertension |
6.5% |
| Myocardial Infarction |
6.5% |
| Carotid Artery Stenosis |
4.8% |
| Drug Use For Unknown Indication |
4.8% |
| Coronary Angioplasty |
3.2% |
| Myocardial Ischaemia |
3.2% |
| Prophylaxis |
3.2% |
| Pyrexia |
3.2% |
| Spinal Anaesthesia |
3.2% |
| Stent Placement |
3.2% |
| Thrombosis Prophylaxis |
3.2% |
| Transient Ischaemic Attack |
3.2% |
| Angioplasty |
1.6% |
| Anticoagulant Therapy |
1.6% |
| Bipolar Disorder |
1.6% |
| Cerebral Infarction |
1.6% |
| Cerebrovascular Accident |
1.6% |
| Colitis Ulcerative |
1.6% |
|
| Diarrhoea |
8.0% |
| Normochromic Normocytic Anaemia |
8.0% |
| Post Procedural Haemorrhage |
8.0% |
| Thrombotic Microangiopathy |
8.0% |
| Thrombotic Thrombocytopenic Purpura |
8.0% |
| Aspergillosis |
4.0% |
| Bronchial Haemorrhage |
4.0% |
| Cerebral Haemorrhage |
4.0% |
| Cholestasis |
4.0% |
| Diarrhoea Haemorrhagic |
4.0% |
| Drug Rash With Eosinophilia And Systemic Symptoms |
4.0% |
| Gastrointestinal Tract Adenoma |
4.0% |
| Haematemesis |
4.0% |
| Hemiparesis |
4.0% |
| Hepatitis Cholestatic |
4.0% |
| Hypertensive Crisis |
4.0% |
| Leukopenia |
4.0% |
| Lupus-like Syndrome |
4.0% |
| Myalgia |
4.0% |
| Neuroborreliosis |
4.0% |
|
| Secondary |
| Drug Use For Unknown Indication |
28.2% |
| Acute Myocardial Infarction |
10.0% |
| Cerebral Infarction |
9.3% |
| Antiplatelet Therapy |
7.7% |
| Hypertension |
6.2% |
| Myocardial Infarction |
3.9% |
| Dementia Alzheimer's Type |
3.5% |
| Cerebrovascular Accident |
3.1% |
| Wound Infection |
3.1% |
| Anticoagulant Therapy |
2.7% |
| Diabetes Mellitus |
2.7% |
| Gastritis |
2.7% |
| Arteriosclerosis Obliterans |
2.3% |
| Coronary Artery Bypass |
2.3% |
| Prophylaxis |
2.3% |
| Thrombosis Prophylaxis |
2.3% |
| Angina Pectoris |
1.9% |
| Dialysis |
1.9% |
| Hyperlipidaemia |
1.9% |
| Inflammation |
1.9% |
|
| Toxic Epidermal Necrolysis |
10.0% |
| Cardiac Tamponade |
6.0% |
| Interstitial Lung Disease |
6.0% |
| Liver Disorder |
6.0% |
| Mediastinal Haematoma |
6.0% |
| Rhabdomyolysis |
6.0% |
| Stevens-johnson Syndrome |
6.0% |
| Supraventricular Extrasystoles |
6.0% |
| Tracheal Stenosis |
6.0% |
| Cholestatic Liver Injury |
4.0% |
| Colitis Collagenous |
4.0% |
| Fall |
4.0% |
| Gastrointestinal Necrosis |
4.0% |
| Leukocytoclastic Vasculitis |
4.0% |
| Liver Injury |
4.0% |
| Sepsis |
4.0% |
| Serotonin Syndrome |
4.0% |
| Shock Haemorrhagic |
4.0% |
| Thrombotic Thrombocytopenic Purpura |
4.0% |
| Aplasia Pure Red Cell |
2.0% |
|
| Concomitant |
| Product Used For Unknown Indication |
18.1% |
| Hypertension |
16.6% |
| Drug Use For Unknown Indication |
13.4% |
| Rheumatoid Arthritis |
9.2% |
| Diabetes Mellitus |
6.6% |
| Thrombosis Prophylaxis |
3.4% |
| Cerebral Infarction |
3.3% |
| Constipation |
2.8% |
| Insomnia |
2.5% |
| Osteoporosis |
2.5% |
| Hypercholesterolaemia |
2.4% |
| Myocardial Infarction |
2.4% |
| Depression |
2.3% |
| Hyperparathyroidism Secondary |
2.3% |
| Angina Pectoris |
2.2% |
| Myocardial Ischaemia |
2.2% |
| Anaemia |
2.0% |
| Coronary Artery Disease |
2.0% |
| Gastritis |
1.8% |
| Cardiac Failure |
1.7% |
|
| Pyrexia |
8.2% |
| Vomiting |
8.2% |
| Ileus Paralytic |
7.3% |
| Osteonecrosis |
6.4% |
| Paralysis |
6.4% |
| Chronic Obstructive Pulmonary Disease |
5.5% |
| Malaise |
5.5% |
| Myocardial Infarction |
5.5% |
| Somnolence |
5.5% |
| Syncope |
5.5% |
| Ventricular Tachycardia |
5.5% |
| Skin Ulcer |
4.5% |
| Constipation |
3.6% |
| Prostate Cancer |
3.6% |
| Rhabdomyolysis |
3.6% |
| Septic Shock |
3.6% |
| Wheezing |
3.6% |
| Anaemia |
2.7% |
| Atrial Flutter |
2.7% |
| Convulsion |
2.7% |
|
| Interacting |
| Essential Thrombocythaemia |
75.0% |
| Thrombocytosis |
25.0% |
|
|
